Clinical Trials Browser

OTHER × Hemangiosarcoma × RNA, Messenger × Clear all

NCT05799612 2026-02-13

Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma

Phase 1 Withdrawn

Hemangiosarcoma